MedTrace Logo

In-office Placement of the Propel Mini Sinus Implant in the Frontal Sinus Ostia

NCT02880514 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-12-10

Study results available
· View outcomes & findings →

Summary

A randomized controlled trial

Conditions

  • Chronic Sinusitis

Interventions

DEVICE

PROPEL Mini Sinus Implant

Sinus implant with 370 mcg of mometasone furoate released over 30 days

PROCEDURE

Balloon Sinus Dilation Alone

Sponsors & Collaborators

  • Intersect ENT

    lead INDUSTRY

Principal Investigators

  • Stacey Silvers · Madison ENT

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2016-12-31
Completion
2017-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02880514 on ClinicalTrials.gov